Coexistent Marfan's syndrome and ankylosing spondylitis

Journal of Rheumatology

Volumn 33, Issue 6, 2006, Pages 1199-1200

  Kiss, Csaba ^a   Jónap, Ildiko ^b   Gergely Jr , Peter ^b   Poór, Gyula ^b  

^a NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^b NONE

Author keywords

Ankylosing spondylitis; Fibrillin 1; Marfan's syndrome

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRILLIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CASE REPORT; CELLULAR IMMUNITY; COMORBIDITY; FBN1 GENE; FEMALE; GENE; GENE MUTATION; HIP SURGERY; HUMAN; INFLAMMATION; MARFAN SYNDROME; PATHOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL;

ADULT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MARFAN SYNDROME; MICROFILAMENT PROTEINS; MUTATION; SPONDYLITIS, ANKYLOSING;

EID: 33744760210     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marfan AB. Une cas de déformation congénitale des quatre members, plus prononcée aux extremités, caractérisée par l' allongement des os avec un certain degré d'aminicissement. Bull Mem Soc Med Hop Paris 1896;13:220-6.
2. Prockop DJ, Kuivaniemi H, Tromp G. Heritable disorders of connective tissue. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, editors. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill; 1994:2105-17.
3. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337-9.
4. Zhang H, Hu W, Ramirez F. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J Cell Biol 1995;129:1165-76.
5. van der Linden S, van der Heijde D. Ankylosing spondylitis. In: Ruddy S, Harris ED Jr, Sledge CB, editors. Kelley's textbook of rheumatology. 6th ed. Philadelphia: WB Saunders; 2001:1039-53.
6. Fietta P, Manganelli P. Coexisting Marian's syndrome and ankylosing spondylitis: a case report. Clin Rheumatol 2001;20:140-2.
7. Rovensky J, Zlnay M, Zlnay D. Marfan syndrome and ankylosing spondylitis [letter]. Isr Med Assoc J 2003;5:153.
8. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417-26.
9. Bennet PH, Wood PHN. Population studies of the rheumatic diseases. In: Bennet PH, Wood PHN, editors. Proceedings of the 3rd International Symposium, 1966. New York: Excerpta Medica Foundation; 1968:456.
10. Yule SR, Hobson EE, Dean JC, Gilbert FJ. Protrusio acetabuli in Marian's syndrome. Clin Radiol 1999;54:95-7.
11. Simkin PA. Acetabular osteitis in ankylosing spondylitis: does fibrillin figure in its pathogenesis? J Rheumatol 2001;28:2663-6.
12. Fietta P, Manganelli P. Is fibrillin-1 the link between ankylosing spondylitis and Marian's syndrome? J Rheumatol 2002;29:1808.
13. Byers PH. Determination of the molecular basis of Marfan syndrome: a growth industry. J Clin Invest 2004;114:160-3.
14. Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995;38:499-505.
15. Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995;75:157-60.